Nisa Investment Advisors, LLC Celldex Therapeutics, Inc. Transaction History
Nisa Investment Advisors, LLC
- $29.3 Billion
- Q4 2025
A detailed history of Nisa Investment Advisors, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 905 shares of CLDX stock, worth $23,122. This represents 0.0% of its overall portfolio holdings.
Number of Shares
905
Previous 1,395
35.13%
Holding current value
$23,122
Previous $36,000
36.11%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CLDX
# of Institutions
205Shares Held
66.6MCall Options Held
222KPut Options Held
234K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$156 Million13.34% of portfolio
-
Wellington Management Group LLP Boston, MA5.8MShares$148 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.03MShares$103 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.89MShares$99.5 Million0.2% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.2B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...